Alchemab Therapeutics vs Mironid
Alchemab Therapeutics vs Mironid, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alchemab Therapeutics is on 42/100 and Mironid on 59/100.
Where each one leads
Alchemab Therapeutics
- agent readiness: 36/100 against 21/100
- domain rating: 33/100 against 13/100
Mironid
- our overall score: 59/100 against 42/100
- funding raised: $46.0M against $31.5M
At a glance
| Measure | Alchemab Therapeutics | Mironid |
|---|---|---|
| What it is | Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals. | Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD). |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery | Biotechnology, Pharmaceuticals, Drug Discovery, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2019 | 2015 |
| Headquarters | London, United Kingdom | Glasgow, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Alchemab Therapeutics | Mironid |
|---|---|---|
| Employees | Not published | 16 |
| Total funding | $31.5M | $46.0M |
| Latest round | Series A | Series B |
| LinkedIn followers | Not published | 1,388 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alchemab Therapeutics | Mironid |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 59/100 |
| Traction | 37/100 | 51/100 |
| Team | Not published | 70/100 |
| Search visibility | 8/100 | 20/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 13/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alchemab Therapeutics | Mironid |
|---|---|---|
| Hosting | Google Cloud | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Google Analytics 4 | Not detected |
Alchemab Therapeutics vs Mironid: common questions
Which is better, Alchemab Therapeutics or Mironid?
On our 0-100 score Mironid rates higher (59/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Alchemab Therapeutics and Mironid compare on the numbers?
Alchemab Therapeutics leads on agent readiness (36/100 against 21/100), domain rating (33/100 against 13/100). Mironid leads on our overall score (59/100 against 42/100), funding raised ($46.0M against $31.5M).
Read the full Alchemab Therapeutics review and pricing or the Mironid review and pricing. You can also browse other Alchemab Therapeutics alternatives we track.